SoftOx Solutions AS (6FV.F)
- Previous Close
0.0100 - Open
0.0100 - Bid 0.0100 x --
- Ask 0.0386 x --
- Day's Range
0.0100 - 0.0100 - 52 Week Range
0.0100 - 0.7420 - Volume
2,000 - Avg. Volume
0 - Market Cap (intraday)
9.329M - Beta (5Y Monthly) -2.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SoftOx Solutions AS, together with its subsidiaries, operates as a medtech and clinical-stage pharmaceutical company in Norway. It offers disinfection products, which includes SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin; and EffectDesH, a surface disinfectant, which has a broad spectrum inactivation effect on bacteria, viruses, yeast, fungi, mycobacterium, and spores. The company also provides human wound and infection treatment products comprising SoftOx Wound Irrigation solutions for acute and chronic wounds to prevent and treat infections including biofilms; and SoftOx Anti-infectives, which aims to treat and remove topical infections in wounded and mucosal tissues, such as biofilms, AMR microbes, viruses, and fungi. In addition, its developing antiseptic solutions for pets and livestock, as well as humans; and inhalation solution, a novel and self-administered inhaled drug for early treatment and prevention of influenza-like illnesses. The company was incorporated in 2012 and is headquartered in Fornebu, Norway.
soft-ox.comRelated News
Performance Overview: 6FV.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6FV.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6FV.F
Valuation Measures
Market Cap
9.33M
Enterprise Value
11.93M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.09
Price/Book (mrq)
2.18
Enterprise Value/Revenue
1.53
Enterprise Value/EBITDA
-0.23
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-20.90%
Return on Equity (ttm)
-218.76%
Revenue (ttm)
6.98M
Net Income Avi to Common (ttm)
-42.08M
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
7.65M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
8.93M
Company Insights: 6FV.F
6FV.F does not have Company Insights